Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study
Crossref DOI link: https://doi.org/10.1186/s12888-016-1020-5
Published Online: 2016-09-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haessler, Frank
Gaese, Franziska
Huss, Michael
Kretschmar, Christoph
Brinkman, Marc
Peters, Helmut
Elstner, Samuel
Colla, Michael
Pittrow, David
Funding for this research was provided by:
Novartis Pharma
License valid from 2016-09-10